These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 1884741)

  • 1. Intraindividual variation in 6-mercaptopurine pharmacokinetics during oral maintenance therapy of children with acute lymphoblastic leukaemia.
    Lafolie P; Hayder S; Björk O; Peterson C
    Eur J Clin Pharmacol; 1991; 40(6):599-601. PubMed ID: 1884741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rectal bioavailability of 6-mercaptopurine in children with acute lymphoblastic leukaemia: partial avoidance of "first-pass" metabolism.
    Kato Y; Matsushita T; Uchida H; Egi S; Yokoyama T; Mohri K
    Eur J Clin Pharmacol; 1992; 42(6):619-22. PubMed ID: 1623901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variability of 6-mercaptopurine pharmacokinetics during oral maintenance therapy of children with acute leukemia.
    Lafolie P; Björk O; Hayder S; Ahström L; Peterson C
    Med Oncol Tumor Pharmacother; 1989; 6(4):259-65. PubMed ID: 2615529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma and erythrocyte concentrations of mercaptopurine after oral administration in children.
    Lönnerholm G; Kreuger A; Lindström B; Ludvigsson J; Myrdal U
    Pediatr Hematol Oncol; 1986; 3(1):27-35. PubMed ID: 3153216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fat body mass and pharmacokinetics of oral 6-mercaptopurine in children with acute lymphoblastic leukemia.
    Zuccaro P; Guandalini S; Pacifici R; Pichini S; Di Martino L; Guiducci M; Giuliano M; Di Tullio MT; Pettoello Mantovani M
    Ther Drug Monit; 1991 Jan; 13(1):37-41. PubMed ID: 2057989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of food intake on bioavailability of oral 6-mercaptopurine in children with acute lymphoblastic leukemia.
    Riccardi R; Balis FM; Ferrara P; Lasorella A; Poplack DG; Mastrangelo R
    Pediatr Hematol Oncol; 1986; 3(4):319-24. PubMed ID: 3153245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and distribution of 6-mercaptopurine administered intravenously in children with lymphoblastic leukaemia.
    Jacqz-Aigrain E; Nafa S; Médard Y; Bessa E; Lescoeur B; Vilmer E
    Eur J Clin Pharmacol; 1997; 53(1):71-4. PubMed ID: 9349933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and pharmacodynamics of oral methotrexate and mercaptopurine in children with lower risk acute lymphoblastic leukemia: a joint children's cancer group and pediatric oncology branch study.
    Balis FM; Holcenberg JS; Poplack DG; Ge J; Sather HN; Murphy RF; Ames MM; Waskerwitz MJ; Tubergen DG; Zimm S; Gilchrist GS; Bleyer WA
    Blood; 1998 Nov; 92(10):3569-77. PubMed ID: 9808549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral mercaptopurine in childhood leukemia: influence of food intake on bioavailability.
    Lönnerholm G; Kreuger A; Lindström B; Myrdal U
    Pediatr Hematol Oncol; 1989; 6(2):105-12. PubMed ID: 2702064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The course of biological parameters and 6-mercaptopurine pharmacokinetics during maintenance treatment of children with acute lymphoblastic leukaemia.
    Hayder S; Björk O; Lafolie P
    Acta Paediatr Scand; 1990; 79(8-9):832-7. PubMed ID: 2239280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of mercaptopurine: plasma drug and red cell metabolite concentrations after an oral dose.
    Welch J; Lennard L; Morton GC; Lilleyman JS
    Ther Drug Monit; 1997 Aug; 19(4):382-5. PubMed ID: 9263376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-dependent kinetics of orally administered 6-mercaptopurine in children with leukemia.
    Kato Y; Matsushita T; Chiba K; Hijiya N; Yokoyama T; Ishizaki T
    J Pediatr; 1991 Aug; 119(2):311-6. PubMed ID: 1861221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of tablet and liquid formulations of oral 6-mercaptopurine in children with acute lymphoblastic leukemia.
    Larsen RH; Hjalgrim LL; Grell K; Kristensen K; Pedersen LG; Brünner ED; Als-Nielsen B; Schmiegelow K; Nersting J
    Cancer Chemother Pharmacol; 2020 Jul; 86(1):25-32. PubMed ID: 32519032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiologically based pharmacokinetic modelling of methotrexate and 6-mercaptopurine in adults and children. Part 2: 6-mercaptopurine and its interaction with methotrexate.
    Ogungbenro K; Aarons L;
    J Pharmacokinet Pharmacodyn; 2014 Apr; 41(2):173-85. PubMed ID: 24651962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large interindividual variations in the pharmacokinetics of oral 6-mercaptopurine in maintenance therapy of children with acute leukaemia and non-Hodgkin lymphoma.
    Lafolie P; Hayder S; Björk O; Ahström L; Liliemark J; Peterson C
    Acta Paediatr Scand; 1986 Sep; 75(5):797-803. PubMed ID: 3564948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is 6-thioguanine more appropriate than 6-mercaptopurine for children with acute lymphoblastic leukaemia?
    Lennard L; Davies HA; Lilleyman JS
    Br J Cancer; 1993 Jul; 68(1):186-90. PubMed ID: 8318412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 6-mercaptopurine plasma levels in children with acute lymphoblastic leukemia: relation to relapse risk and myelotoxicity.
    Hayder S; Lafolie P; Björk O; Peterson C
    Ther Drug Monit; 1989 Nov; 11(6):617-22. PubMed ID: 2595740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacokinetics of 6-mercaptopurine in children with acute lymphoblastic leukemia--interindividual and intraindividual variations].
    Hijiya N; Kato Y; Matsushita T; Yokoyama T
    Rinsho Ketsueki; 1989 Nov; 30(11):1931-6. PubMed ID: 2607612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mercaptopurine metabolism and risk of relapse in childhood lymphoblastic leukaemia.
    Lilleyman JS; Lennard L
    Lancet; 1994 May; 343(8907):1188-90. PubMed ID: 7909868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An improved HPLC method for the quantitation of 6-mercaptopurine and its metabolites in red blood cells.
    Oliveira BM; Romanha AJ; Alves TM; Viana MB; Zani CL
    Braz J Med Biol Res; 2004 May; 37(5):649-58. PubMed ID: 15107925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.